Projects INTERNATIONAL
Pharmacogenomics of Psoriatic Arthritis Using Multi-omics (PHARAO)
Principal Investigator: José Manuel Dodero Anillo (EM15)
More information
Dates: March 1 , 2026 – March 1, 2029
Partners: (Belgium) Hasselt University – UHasselt, Department of Immunology and Infection, Biomedical Research Institute, Veerle Somers, Research Foundation – Flanders (FWO) | (Austria) Austrian Institute of Technology GmbH (AIT), Center for Health and Bioressources, Klemens Vierlinger, Austrian Science Fund (FWF) | (Austria) Medical University of Vienna, Department of Internal Medicine III, Division of Rheumatology, Michael Bonelli, Austrian Science Fund (FWF) | (Spain) Foundation for the Management of Biomedical Research in Cádiz, Clinical Pharmacology Unit, José Manuel Dodero, CSCJA, Department of Health and Consumer Affairs of the Regional Government of Andalusia | (Spain) Pere Virgili Institute for Health Research (IISPV), Interdisciplinary Metabolomics Laboratory/Metabolomics Platform (MIL@b), Maria Vinaixa, Department of Health – Government of Catalonia (DS-CAT)
Budget: 124, 945.00 €
Digital Twin Framework for Tailored Infant Nutrition (GALATEA)
Principal Investigator: Simón Lubián (CO20)
Links: https://galateahe.eu/
More information
Dates: September 1 , 2024 – August 31, 2028
Partners: SCUOLA UNIVERSITARIA PROFESSIONALE DELLA SVIZZERA ITALIANA (Switzerland) | TOELT GMBH (Switzerland)
Budget: 77,400.00 €
The European Youth Cancer Network (YARN)
Principal Investigator: David Jiménez Pavon (CO8)
Links: https://beatcancer.eu/
More information
Dates:July 1, 2025 – June 30, 2028
Budget: €285,621.52
Persistent Atrial Fibrillation: Substrate-Targeted Strategy (PERSUADE)
Principal Investigator: Etelvino Silva (CO31)
More information
Dates: January 1 , 2024 – December 31, 2026
Partners: (AT) Federal Ministry of Education, Science, and Research – (BMBWF) | (AT) AUSTRIAN SCIENCE FUND – (FWF) | (BE) OWN FUNDS OF THE INSTITUTE FOR AGRICULTURAL AND FISHERIES RESEARCH – (EV ILVO) | (BE) FONDS DE LA RECHERCHE SCIENTIFIQUE-FNRS – (FRS-FNRS) | (BE) FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN – (FWO) | (CZ) MINISTRY OF HEALTH – (MZCR) | (DE) GERMAN AEROSPACE CENTER (DLR) | (DE) FEDERAL MINISTRY OF EDUCATION AND RESEARCH (BMBF) | (DK) INNOVATION FUND – (IFD) | (EE) THE ESTONIAN RESEARCH COUNCIL – (ETAG) | (EG) ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY – (ASRT) | (EL) GENERAL SECRETARIAT FOR RESEARCH AND INNOVATION – (GSRI) | (ES) CARLOS III HEALTH INSTITUTE – (ISCIII) | (ES) STATE RESEARCH AGENCY – (AEI) | (ES) FOUNDATION FOR THE PROMOTION OF SCIENTIFIC RESEARCH AND TECHNOLOGY IN ASTURIAS – (FICYT) | (ES) DEPARTMENT OF HEALTH AND CONSUMER AFFAIRS OF THE REGIONAL GOVERNMENT OF ANDALUSIA – (CSCJA) | (ES) ASTURIAN AGENCY FOR SCIENCE, BUSINESS COMPETITIVENESS, AND INNOVATION – (SEKUENS) | (FR) NATIONAL RESEARCH AGENCY – (ANR) | (FR) EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK – (ECRIN) | (FR) MINISTRY OF HEALTH AND ACCESS TO HEALTH CARE – (Fr-MoH) | (HU) National Office for Research, Development, and Innovation – (NKFIH) | (IE) The Health Research Board – (HRB) | (IL) Ministry of Health – (CSO-MOH) | (IT) MINISTRY OF HEALTH – (IT-MOH) | (IT) MINISTRY OF UNIVERSITIES AND RESEARCH – (MUR) | (LT) LITHUANIAN SCIENCE COUNCIL – (LMT) | (LV) LATVIAN COUNCIL OF SCIENCE – (LCS) | (NL) NETHERLANDS ORGANIZATION FOR SCIENTIFIC RESEARCH – (NWO) | (NL) HEALTH RESEARCH NETHERLANDS ZON – (ZonMw) | (NO) NORWEGIAN RESEARCH COUNCIL – (RCN) | (PL) NATIONAL CENTER FOR RESEARCH AND DEVELOPMENT – (NCBR) | (PT) AGENCY FOR CLINICAL RESEARCH AND BIOMEDICAL INNOVATION – (AICIB) | (PT) FOUNDATION FOR SCIENCE AND TECHNOLOGY – (FCT) | (RO) EXECUTIVE UNIT FOR FUNDING HIGHER EDUCATION, RESEARCH, DEVELOPMENT, AND INNOVATION – (UEFISCDI) | (SK) SLOVAK ACADEMY OF SCIENCES – (SAS) | (SK) BIOMEDICAL CENTER OF THE SLOVAK ACADEMY OF SCIENCES, PUBLIC RESEARCH INSTITUTION – (BMC-SAS) | (TR) TURKISH SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL – (TUBITAK)
Budget: 249,623.00 €
CHILD MENTAL HEALTH LITERACY: CO-CREATING AND EVALUATING A WHOLE-SCHOOL INTERVENTION AND DEVELOPING AND VALIDATING AN AD HOC SCALE (CHILD MENTAL HEALTH)
Principal Investigator: Juan Luis González Caballero (CO15)
More information
Dates: January 1 , 2024 – December 31, 2026
Luminescent Implants as Ports for Light-Based Therapies (PHOtoTHERAPORT)
Principal Investigator: Esther Berrocoso (CO9)
More information
Dates:January 1, 2024 – December 31, 2026
Budget: 405,500.00 €
A Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Principal Investigator: Ángel Estella (EM11)
More information
Dates:February 2, 2023 – March 28, 2026
Budget: 3,750.00 €
Prevention and Management Tools for Reducing Antibiotic Resistance in High-Prevalence Settings (REVERSE)
Principal Investigator: Salvador López Cárdenas (EM11)
More information
Dates: July 1, 2021 – September 30, 2025
Partners: University of Zurich, Partner Lead (Project Coordinator): Walter Zingg, Partner Lead (WP5): Lauren Clack | Andalusian Health Service, Partner Lead: Jesús Rodríguez Baño | Barcelona Institute for Global Health, Partner Lead: Elisa Sicuri | National and Kapodistrian University of Athens, Partner Lead: George Daikos | Tel Aviv Sourasky Medical Center, Partner Lead: Yehuda Carmeli | UK n Health Security Agency, Partner Lead: Julie Robotham | University Medical Center Utrecht, Partner Lead: Jan Kluytmans | University of Florence, Partner Lead: Gian Maria Rossolini | University of Geneva, Partner Lead: Stephan Harbarth | Carol Davila University of Medicine and Pharmacy, Partner Lead: Adriana Hristea | University of Oxford, Partner Lead: Koen Pouwels | University of Verona, Partner Lead: Evelina Tacconelli
Budget: 300,000.00 €
Pathophysiology of Neural Circuits Underlying Pain in Parkinson's Disease, from the Prodromal Stage to Advanced Stages
Principal Investigator: Esther Berrocoso (CO9)
More information
Dates:October 1, 2023 – September 30, 2025
Partners: The Michael J. Fox Foundation (MJFF) works with companies to enhance our programs through funding, in-kind contributions, strategic input, and more. Partners make these key MJFF initiatives possible | Parkinson’s Progression Markers Initiative (PPMI): A landmark longitudinal study to identify objective measures of Parkinson’s disease, PPMI is an MJFF-sponsored study, funded by MJFF and a consortium of companies, nonprofit organizations, and private individuals | Fox Insight: Sponsored by MJFF, Fox Insight is an online clinical study that collects genetic and self-reported data from a diverse group of people with and without Parkinson’s. Fox Insight aims to transform the search for Parkinson’s treatments by building a more comprehensive understanding of the disease | Parkinson’s Disease Research Tools Consortium: The Foundation leads the Parkinson’s Disease Research Tools Consortium. This pre-competitive consortium helps MJFF and industry partners identify and develop new preclinical tools to address unmet research needs and accelerate experiments | Accelerating Medicines Partnership Parkinson’s Disease Program (AMP PD), This public-private partnership between MJFF, the National Institutes of Health (NIH), and five life sciences companies—managed by the Foundation for the NIH—is advancing the understanding, measurement, and treatment of Parkinson’s disease. AMP PD supports cutting-edge research to identify microscopic differences in the cells of people with Parkinson’s disease from samples collected through MJFF- and NIH-supported studies | Parkinson’s Disease Education Consortium: Patient and caregiver education and engagement lead to better health outcomes for both individuals and the broader community through specialized care, the use of new treatments, and participation in clinical research. Our Parkinson’s Disease Education Consortium is an alliance of biotechnology and pharmaceutical companies that support our commitment to providing high-quality educational resources for the Parkinson’s community. Resources include annual education campaigns, webinars and podcasts, videos and website content, and in-person events | Parkinson’s Disease Therapeutics Conference, The only conference focused exclusively on Parkinson’s drug development, MJFF’s annual Parkinson’s Disease Therapeutics Conference attracts 300 research and business development professionals from academia and industry, and showcases the most promising, innovative research from the MJFF portfolio | MDS-PAS Movement Disorders School for Neurology Residents, In partnership with the International Parkinson and Movement Disorder Society (MDS), MJFF hosts the MDS-PAS Movement Disorders School for Neurology Residents. Through this program, neurology residents learn about movement disorders and consider specializing in the field, thereby expanding the pool of specialists caring for people with Parkinson’s disease | The Bachmann-Strauss Fellowship in Dystonia Research, In 2014, the Bachmann-Strauss Dystonia & Parkinson Foundation formed a collaborative research alliance with MJFF and established the Bachmann-Strauss Prize for Excellence in Dystonia Research to raise public awareness and recognize key scientific discoveries in dystonia. In 2021, MJFF, in partnership with Bonnie and Tom Strauss, launched the Bachmann-Strauss Fellowship in Dystonia Research to expand the pool of scientists working to understand the causes of and factors contributing to dystonia | Shake It Up Foundation Australia: MJFF collaborates with the Shake It Up Foundation Australia to raise funds for PPMI and other Parkinson’s research being conducted in Australia. Together, the two organizations leverage MJFF’s expertise in Parkinson’s drug development to ensure that funds are allocated to projects that will tangibly improve patients’ lives | The Michael Stern Parkinson’s Research Foundation: The Michael Stern Parkinson’s Research Foundation (MSPRF) was founded in 2001 by the late journalist, filmmaker, and philanthropist Michael Stern. Over the course of its 15 years of operation, MSPRF has supported more than $46 million in Parkinson’s disease research. In 2015, the Stern Foundation designated MJFF as its successor organization and established the Michael Stern Discovery Grants in Parkinson’s Science to advance research focused on the underlying causes, diagnosis, and treatment of PD
Budget: €111,187.07
Projects 'S INTERNATIONAL RECORD
Multicenter Study of the Efficacy of a Single Course of BIC/FTC/TAF in Institutionalized Prisoners Living with HIV (Multicenter Study of the Efficacy of a Single Course of BIC/FTC/TAF in Institutionalized Prisoners Living with HIV)
More information
Dates:October 5, 2023 – 2026
Budget: 42,895.00 €
Comorbidity of Chronic Pain and Mood Disorders: Breaking the Vicious Cycle (HaPpY)
Principal Investigator: Esther Berrocoso (CO9)
More information
Dates: July 1 , 2021 – June 30, 2025
Socios: Ipek Yalcin (Pharm.D., Ph.D). Research Director at CNRS (DR2). Co-head of “Neuroanatomy, Pain and Psychopathology”. Adjunct Professor at Psychiatry & Neuroscience at Laval University. Scientific Coordinator of HaPpY ITN project | Michel Barrot (Ph.D.). Research Director at CNRS. Director of the CNRS «Institut des Neurosciences Cellulaires & Intégratives» (UPR3212). Scientific Director of the EUR Euridol (Graduate School of Pain) at Strasbourg University. Neuroanatomy, Pain & Psychopathology» team co-leader | Pierre-Eric Lutz (M.D., Ph.D.). Associate Professor, CNRS. Researcher at Institut des Neurosciences Cellulaire et Intégratives | Professor Yves de Koninck (Ph.D). Professor of psychiatry & Neuroscience at Laval University. Adjunct Professor of Pharmacology & Therapeutics at McGill University. Scientific Director, Cervo Brain Research Center. Director of research, Quebec Integrated University Health and Social Services Center. Director, Neurophotonics Center. Scientific Director, Sentinel North Initiative. Fellow, Canadian Academy of Health Sciences. Fellow, Royal Society of Canada. Canada Research Chair in Chronic Pain and Related Brain Disorders – Tiers 1 | Tomi Rantamäki (Ph.D.). Associate Professor, University of Helsinki. Researcher at Laboratory of Neurotherapeutics, Regenerative Pharmacology Unit. Member of Council in the Brain Research Society Finland (BRSF). Member of Finnish Pharmaceutical Association and Finnish Pharmacological Society | Michelle Roche (Ph.D.). Senior Lecturer in Physiology at the National University of Ireland, Galway. Co-director for the Center for Pain Research. Deputy Director for the Galway Neuroscience Center | David Finn (Ph.D.). Professor at the National University of Ireland (NUI) Galway. Head of Pharmacology and Therapeutics Department. Research Officer, Galway Neuroscience Centre. Scientific Advisory Panel of the European College of Neuropsychopharmacology (ECNP) board member. Founding Co-Director of the Centre for Pain Research at the National University of Ireland (NUI) Galway. Member of the International Association for the Study of Pain (IASP) and European Pain Federation (EFIC) Presidential Task Forces for Cannabis, Cannabinoids and Chronic Pain | Esther Berrocoso (Ph.D.). University of Cadiz tenured Professor. Head of research group – Principal investigator at Instituto de Investigacion e Innovacion Biomédica de Cadiz | Frauke Nees (Ph.D.). Director of the Institute of Medical Psychology and Sociology. Professor at the Institute of Medical Psychology and Sociology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Campus Kiel | Herta Flor (Ph.D.). Scientific Director, Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim. Full Professor, Heidelberg University, Germany. Member of the Research Advisory Board of the Cluster of Excellence „NeuroCure“ at the Charité – Universitätsmedizin, Berlin, Germany. Spokesperson of the interdisciplinary graduate program “Translational Neurosciences” of the Collaborative Research Center 636, funded by the Deutsche Forschungsgemeinschaft. Member of the German Academy of Sciences Leopoldina. Member of the Academia Europaea | Hugo Almeida (Ph.D.). Adjunct Professor, Life and Health Sciences Research Institute, Do Minho University. Junior Researcher | Benoit Labonté (Ph.D.). Assistant Professor, Psychiatry and Neuroscience department, Medicine University, Laval University. Research Chair – North Sentinelle in molecular biology and mood disorders | Rohini Kuner (Ph.D.). Professor, Department of Pharmacology, INF 366, Heidelberg University. Group leader in the Molecular Medicine Partnership Unit. | Eric Salvat (M.D. & Ph.D.). Coordinator of the Center for Pain Evaluation and Treatment (CETD), Strasbourg University Hospital. Associated Professor. Doctor specialized in Pain Treatment | Jack Foucher (M.D. & Ph.D.). Coordinator at the Center of Non-Invasive neuro-Modulation (CEMNIS), Strasbourg University Hospital. Lecturer, Strasbourg University. Neurologist, Psychiatrist & Physiologist | Didier Bouhassira (M.D. & Ph.D.). Professor and Research Director, INSERM. Head of the «Pathophysiology and clinical pharmacology of pain» laboratory, Paris Saclay University. Neurologist, Universitary Hospital Paris Ile-de-France Ouest | Nadine Attal (M.D. & Ph.D.). Professor and Research co-Director, INSERM. Neurologist, Universitary Hospital Paris Ile-de-France Ouest. Researcher in the «Pathophysiology and clinical pharmacology of pain» laboratory, Paris Saclay University | Jean-Luc Néron, Ph.D. Secondments for 4 ESRs. Development and optimization of optogenetic tolos | Domitille Boudard, Ph.D. Secondment for 1 ESR. Management, communication and dissemination | Stéphanie Wagner, Ph.D/ Emile Andriambeloson. Secondment for 2 ESRs. Behavioral testing and data comparison | Matthieu Charvériat Ph.D. Secondment for 3 ESRs. Development of strategies for «bed to bedside» | Ewa Sokolowska, Ph.D./Jack Prenderville, Ph.D. Secondments for 2 ESRs. Entrepreneurial skills | Sam Kynman. Secondment for 1 ESR. Management, communication and dissemination | Augusto Eugénio Filipe Ph.D. Secondment for 2 ESRs. Product development and marketing | Frauke Nees Ph.D. Secondment for 1 ESR. Clinical coach / dissemination activites | European Network of Fibromyalgia Associations (Belgium) | Fybromyalgia France (France) | European Psychiatry Association (Belgium) | Société Française D’Etude et De Traitement De La Douleur (France) | Sociedad Espanola Del Dolor (Spain) | L’institut Français De Finlande (Finland) | Centro De Investigacion Biomedica En Red Salud Mental (Spain) | Alsace Biovalley (France) | Pain Alliance Europe (Belgium) | European Depression Association (Belgium) | European Brain Council (Belgium) | Association for the Improvement of Mental Health Programmes (Switzerland)
Budget: €501,809.75
Premature Newborn Motor and Cognitive Impairments: Early Diagnosis (PARENT)
Principal Investigators: Isabel Benavente and Simón Lubián (CO20)
More information
Dates: November 1 , 2020 – April 30, 2025
Budget: €501,809.76
A Holistic Approach to Rocking Your Health (RYHEALTH)
Principal Investigator: David Jiménez Pavon (CO8)
Links: https://ryhealth.net/
More information
Dates: November 1 , 2022 – April 30, 2025
Partners: University of Coimbra | Västerbotten Region | Outdoor Against Cancer | Anadia School Group | International Montessori School | University of Cádiz
Budget: €178,348.62
Retinal and Cognitive Dysfunction in Type 2 Diabetes: Unraveling the Common Pathways and Identifying Patients at Risk for Dementia (RECOGNISED)
Principal Investigator: Mónica García Alloza (CO18)
More information
Dates: January 1 , 2020 – December 31, 2024
Partners: FUNDACIO HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA, SPAIN – Coordinator (Rafael Simo) | THE QUEEN’S UNIVERSITY OF BELFAST – THE QUEEN’S UNIVERSITY OF BELFAST, United Kingdom – Deputy Coordinator (Noemi Lois) | AIBILI – ASSOCIATION FOR BIOMEDICAL RESEARCH AND INNOVATION IN LIGHT AND IMAGING, PORTUGAL (José Cunha-Vaz) | UNIVERSITY MEDICAL CENTER UTRECHT – UMC UTRECHT, THE NETHERLANDS (Geert J. Biessels) | ACADEMIC MEDICAL CENTER AT THE UNIVERSITY OF AMSTERDAM – AMC, THE NETHERLANDS (Reinier Schlingemann) | UNIVERSITY OF ROME TOR VERGATA – UNITOV, ITALY (Simona Frontoni / Paolo Sbraccia) | SAN RAFFAELE HOSPITAL SRL – OSR, VIA OLGETTINA 60, MILAN 20132, ITALY (Gianpaolo Zerbini) | UNIVERSITY OF MILAN – UMIL, Via Festa Del Perdono 7, MILAN 20122, ITALY (Tiziana Borsello) | SOUTHERN DENMARK UNIVERSITY – SDU, DENMARK (Jakob Grauslund) | TERRASSA MUTUAL AID FOUNDATION – PRIVATE CATALAN FOUNDATION, SPAIN (Maria José Barahona) | CATALAN HEALTH INSTITUTE – ICS, SPAIN (Xavier Valldeperas) | PUBLIC INSTITUTION UNIVERSITY OF MONTENEGRO, PODGORICA – UOM, MONTENEGRO (Nataša Popović) | CLINICAL CENTER OF MONTENEGRO, PODGORICA – Clinical Center of Montenegro, MONTENEGRO (Filip Vukmirović) | UNIVERSITY OF CÁDIZ – UCA, SPAIN (Mónica Garcia-Alloza) | EATRIS ERIC – EATRIS, THE NETHERLANDS (Anton Ussi) | ALZHEIMER EUROPE – AE, LUXEMBOURG (Jean Georges) | INTERNATIONAL DIABETES FEDERATION EUROPE REGION AISBL – IDF EUROPE, BELGIUM (Sabine Dupont) | ANAXOMICS BIOTECH, S.L., SPAIN (Judith Farrés) | OXURION, BELGIUM (Tine Van Bergen) | GENESIS BIOMED, BALDIRI REIXAC 4, BARCELONA 08028, SPAIN (Josep Lluís Falcó) | MULTIMEDICA SPA, VIA GAUDENZIO FANTOLI 16/15, MILAN 20138, ITALY (Stela Vujosevic)
Budget: €229,672.50
Outdoor Against Cancer Connects Us (OACus)
Principal Investigator: David Jiménez Pavon (CO8)
Links: https://oac-connect.eu/
More information
Dates: June 17 , 2022 – December 16, 2023
Partners: Umeå University | Västerbotten Region | Outdoor Against Cancer | ESV Munich | University of Patras | CreThiDev | University of Palermo | CEIPES | LILT Palermo | University of Cádiz | University of Coimbra | CHUC | Portuguese League Against Cancer
Budget: 156,220.00 €
PROGERIA
Principal Investigator: Mario Cordero (EM4)
More information
Dates: September 1 , 2021 – August 30, 2023
Budget: €126,478.73
Networks
nexMPI (COST)
Principal Investigator: Daniel Ortega (CO24)
Links: https://nexmpi.eu/
Dates: October 22, 2024 – October 21, 2028
IMPROVE (COST)
Principal Investigator: Raúl González Domínguez (CO28)
Links: https://cost-improve.eu/
Dates: October 21, 2022 – October 20, 2026
IMMUPARKNET (COST)
Principal Investigator: Javier González Rosa (CO12)
Dates: September 20, 2022 – September 19, 2026
Vermont Oxford Network (VON)
Principal Investigator: Simón Lubián (CO20)
Links: https://public.vtoxford.org/
Dates: January 1, 2013 – x
Harvard Exchange Alumni Training Program (HEAT-Network)
Principal Investigator: Mónica García Alloza (CO18)
Health Literacy Europe (Alliance)
Principal Investigators: Martina Fernández Gutiérrez, Pilar Bas Sarmiento (EM14)
Dates: April 4, 2019 – x
Retina4Future (COST)
Principal Investigator: Ana I. Arroba Espinosa (CO17)
Dates: October 9, 2025 – October 8, 2029
CINNAMON COST Action
Principal Investigator: Francisco José García Cózar (CO10)
Dates: July 6, 2026 – October 30, 2029
BBMRI-ERIC
Links: https://www.bbmri-eric.eu/
SeaEU (Alliance)
Links: https://sea-eu.org/
HISTORY OF Networks
FOSTREN (COST)
Principal Investigator: José Mª Villagrán (EM10)
Dates: October 22, 2020 – October 21, 2024
reSearch-EU (reSearch-EU)
Principal Investigator: Carmen Castro González (CO5)
Dates: January 1, 2021 – December 31, 2023
BURDEN (COST)
Principal Investigator: Mª José Santi Cano (EM16)
Dates: October 28, 2019 – October 27, 2023
CA16102 (COST)
Principal Investigator: José Miguel Mestre Navas (IN25)
Dates: 2017–2021